Cargando…

When vaccine adverse event reporting generates hope, not fear

Detalles Bibliográficos
Autores principales:	Chang, Joyce C, Son, Mary Beth F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863425/ https://www.ncbi.nlm.nih.gov/pubmed/35216659 http://dx.doi.org/10.1016/S2352-4642(22)00061-X

Ejemplares similares

Vaccine hope is still alive
por: Wilson, Clare
Publicado: (2020)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

Signals of hope: gauging the impact of a rapid national vaccination campaign
por: Shilo, Smadar, et al.
Publicado: (2021)

Offline: Reasons for hope
por: Horton, Richard
Publicado: (2020)

Imatinib in COVID-19: hope and caution
por: Bernal-Bello, David, et al.
Publicado: (2021)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

China's new public health constitution: a cause for hope?
por: Ip, Eric C
Publicado: (2020)

Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia
por: Wood, Nicholas, et al.
Publicado: (2023)

From China: hope and lessons for COVID-19 control
por: Azman, Andrew S, et al.
Publicado: (2020)

PARP inhibition in breast cancer: progress made and future hopes
por: Tung, Nadine, et al.
Publicado: (2022)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

Inter-arm blood pressure difference, when is it a useful risk marker for cardiovascular events?
por: Clark, Christopher E.
Publicado: (2021)

Adverse effects of COVID-19 vaccines and measures to prevent them
por: Yamamoto, Kenji
Publicado: (2022)

Learning from COVID-19 to tackle TB pandemic: From despair to hope
por: Sheikh, Javaid Ahmad, et al.
Publicado: (2022)

Toning down the 2019-nCoV media hype—and restoring hope
por: Ippolito, Giuseppe, et al.
Publicado: (2020)

Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
por: Gronbeck, Christian, et al.
Publicado: (2021)

Next-generation COVID-19 vaccines: here come the proteins
por: Blakney, Anna K, et al.
Publicado: (2021)

We shouldn’t worry when a virus mutates during disease outbreaks
por: Grubaugh, Nathan D., et al.
Publicado: (2020)

Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”
por: Visentin, Andrea, et al.
Publicado: (2021)

Mechanisms of immune-related adverse events associated with immune checkpoint blockade: using germline genetics to develop a personalized approach
por: Khan, Zia, et al.
Publicado: (2019)

CERN hopes LHC report will dispel doomsday fears
Publicado: (2008)

When bubbles burst
por: Petsko, Gregory A
Publicado: (2008)

When bigger is better
por: Petsko, Gregory A
Publicado: (2010)

So far, no novel SARS-CoV-2 variants from Beijing—and hopefully better scientific cooperation going forward
por: Preiser, Wolfgang, et al.
Publicado: (2023)

What can we expect from first-generation COVID-19 vaccines?
por: Peiris, Malik, et al.
Publicado: (2020)

When Wnts antagonize Wnts
por: Weidinger, Gilbert, et al.
Publicado: (2003)

When failure should be the option
por: Petsko, Gregory A
Publicado: (2010)

When the pie is too small
por: Petsko, Gregory A
Publicado: (2010)

Can Humans Discriminate Horse ‘Fear’ Chemosignals from Control Chemosignals? Comment on Sabiniewicz et al. A Preliminary Investigation of Interspecific Chemosensory Communication of Emotions: Can Humans (Homo sapiens) Recognise Fear- and Non-Fear Body Odour from Horses (Equus ferus caballus). Animals 2021, 11, 3499
por: Semin, Gün R., et al.
Publicado: (2022)

New mechanistic insights of the pathogenicity of high-risk cytomegalovirus (CMV) strains derived from breast cancer: Hope for new cancer therapy options
por: Söderberg-Nauclér, Cecilia
Publicado: (2022)

When science comes before progress
por: Stecher, Benjamin
Publicado: (2019)

Stopping epidemics when and where they occur
por: Torreele, Els, et al.
Publicado: (2023)

The Role of COVID-19 Vaccine Perception, Hope, and Fear on the Travel Bubble Program
por: Almokdad, Eeman, et al.
Publicado: (2022)

When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

When disaster strikes fungi take control
por: Hoenigl, Martin
Publicado: (2022)

When will ‘open science’ become simply ‘science’?
por: Watson, Mick
Publicado: (2015)

COVID-19: when should quarantine be enforced?
por: Bauch, Chris T, et al.
Publicado: (2020)

When to consider lung transplantation for COVID-19
por: Cypel, Marcelo, et al.
Publicado: (2020)

COVID-19 and homelessness: when crises intersect
por: Baggett, Travis P, et al.
Publicado: (2021)

Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1vk9td8co3g5g0b5md0d64b528